New York Regional Center for Diabetes Translation Research

纽约糖尿病翻译研究区域中心

• 批准号: 10290453
• 负责人: JEFFREY S GONZALEZ
• 金额: $ 7.89万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-20 至 2026-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10290453
• 关键词: Address; Behavior; Behavioral Sciences; Biological; Biological Markers; Blood Glucose; COVID-19 pandemic; Clinical; Clinical Management; Collaborations; Communities; Comparative Effectiveness Research; Consult; Consultations; Diabetes Mellitus; Diet; Dietary intake; Dissemination and Implementation; Effectiveness; Environment; Evaluation; Evaluation Methodology; Evidence based practice; Evolution; Faculty; Focus Groups; Foundations; Funding; Health; Health Technology; Health behavior; Health behavior change; Health system; Individual; Intervention; Intervention Studies; Intervention Trial; Knowledge; Life Style; Link; Measurement; Measures; Medicine; Methodology; Methods; Mission; Mobile Health Application; National Institute of Diabetes and Digestive and Kidney Diseases; New York; Nutritional Science; Outcome; Outcome Measure; Outcomes Research; Participant; Patient-Focused Outcomes; Pharmaceutical Preparations; Physical activity; Program Effectiveness; Property; Psychology; Quality Control; Reach, Effectiveness, Adoption, Implementation, and Maintenance; Research; Research Methodology; Research Personnel; Resources; Schools; Services; Targeted Research; Technology; Telemedicine; Time; Translational Research; Translations; Ultrasonography; Universities; World Health; base; biopsychosocial; clinical care; college; community based participatory research; community setting; data integration; data streams; design; diabetes risk; diabetes self-management; dissemination research; effectiveness trial; evidence base; experience; handheld mobile device; health disparity; health equity; healthcare community; implementation research; innovation; intervention effect; mHealth; medical schools; monitoring device; novel; psychologic; remote intervention; smartphone Application; social; stakeholder perspectives; theories; translational scientist

Behavioral Science and Technology Core The Behavioral Science and Technology Core (BSTC) of the New York Center for Diabetes Translation Research will provide consultative services and technical support to high-quality translational intervention research that targets diabetes-related health behaviors, using rigorous methods that are informed by multi- stakeholder input and collaboration. Innovatively, BSTC now includes faculty expertise in clinical diabetes and landmark clinical diabetes intervention trials, leveraging a strong link to the NIDDK-funded Einstein-Mount Sinai Diabetes Center. An additional novel BSTC service builds on strengths of our first funding period to promote the use of cutting-edge technologies to measure behavior as it occurs in real-time and in the context of a naturalistic environment, and to deliver mobile health (mHealth) applications and just-in-time interventions. The BSTC brings together a rich set of resources to support translational investigators working to overcome barriers to widespread dissemination and implementation of evidence-based strategies that target clinical management and/or behavior and lifestyle change to reduce diabetes health disparities in real-world health care and community settings. BSTC specific aims are: 1) To support and promote diabetes translation research, grounded in state-of-the-art behavioral science and clinical diabetes, tailored to maximize impact on diabetes health equity. Consultation services support use of cutting-edge behavioral science and clinical diabetes knowledge to refine hypotheses about mechanisms and moderators of intervention effects and guide evaluation plans. 2) To facilitate stakeholder informed and community-engaged translational research methods for maximal real-world impact. Consultation services address community-based participant research and stakeholder engagement methods, providing access to an innovative and highly experienced Diabetes Accelerator, a diabetes translation research focused stakeholder group from diverse backgrounds. 3) To consult on and provide access to innovative mobile health technologies to deliver interventions, tailoring interventions to the needs of individuals at particular moments in time, and measure outcomes. Consultation services address: selecting appropriate technologies, incorporating them into tailored interventions, and using these to reach individuals living with or at risk for diabetes in their natural environments. 4) To facilitate application of rigorous evaluation methods that can advance behavioral science and evidence-based practice. Consultation services address: selecting outcome measures with sound measurement properties, implementing quality control and fidelity assessments, applying advanced statistical, qualitative and mixed- methods in comprehensive assessments of program effectiveness [e.g., reach, effectiveness, adoption, implementation and maintenance (RE-AIM)]. .

行为科学与技术核心 纽约糖尿病翻译中心行为科学与技术核心 (BSTC) 研究将为高质量的转化干预提供咨询服务和技术支持 针对糖尿病相关健康行为的研究，采用严格的方法，由多方提供信息 利益相关者的投入和协作。具有创新性的是，BSTC 现在拥有临床糖尿病和糖尿病领域的教职人员专业知识 具有里程碑意义的临床糖尿病干预试验，利用与 NIDDK 资助的 Einstein-Mount 的紧密联系 西奈糖尿病中心。另一项新颖的 BSTC 服务建立在我们第一个资助期的优势之上 促进使用尖端技术来衡量实时发生的行为 自然环境，并提供移动医疗（mHealth）应用程序和及时干预措施。 BSTC 汇集了丰富的资源来支持转化研究人员努力克服 广泛传播和实施针对临床的循证策略的障碍 管理和/或行为和生活方式的改变，以减少现实世界健康中的糖尿病健康差异 护理和社区环境。 BSTC 的具体目标是： 1) 支持和促进糖尿病转化 研究以最先进的行为科学和临床糖尿病为基础，旨在最大限度地影响 糖尿病健康公平。咨询服务支持使用尖端的行为科学和临床 糖尿病知识，以完善有关干预效果的机制和调节因素的假设并提供指导 评估计划。 2) 促进利益相关者知情和社区参与的转化研究方法 以获得最大的现实世界影响。咨询服务涉及基于社区的参与者研究和 利益相关者参与方法，提供接触创新且经验丰富的糖尿病的机会 Accelerator，一个专注于糖尿病转化研究的来自不同背景的利益相关者群体。 3) 至 咨询并提供创新的移动医疗技术，以提供干预措施、定制 对个人在特定时刻的需求进行干预，并衡量结果。咨询 服务地址：选择适当的技术，将其纳入量身定制的干预措施中，并使用 这些旨在接触到在自然环境中患有糖尿病或有糖尿病风险的个体。 4) 方便 应用严格的评估方法可以推进行为科学和循证实践。 咨询服务地址：选择具有良好测量属性的结果测量， 实施质量控制和保真度评估，应用先进的统计、定性和混合 全面评估计划有效性的方法[例如，范围、有效性、采用率、 实施和维护（RE-AIM）]。 。